# Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs

> **NCT01486862** · PHASE4 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 26 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** biphasic insulin aspart 30

## Key facts

- **NCT ID:** NCT01486862
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2023-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01486862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01486862, "Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01486862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*